Final Results From Early Trials on a Vaccine to Prevent TNBC
December 11, 2025
At the 2025 San Antonio Breast Cancer Symposium, Justin Johnson, PhD, presented a poster detailing the final results from three groups of people in a phase I trial on a vaccine to prevent triple-negative breast cancer.
Listen to the episode to hear Dr. Johnson explain:
- why the vaccine targets the alpha-lactalbumin protein
- the safety and dose results of the study
- what’s next for the research
Listen now or read the transcript.